EGAIN Corp Files 10-Q for Period Ending March 31, 2024

TL;DR

<b>EGAIN Corp has filed its Q3 2024 10-Q, detailing financial positions as of March 31, 2024, and prior periods.</b>

AI Summary

EGAIN Corp (EGAN) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. EGAIN Corp filed its quarterly report (10-Q) for the period ending March 31, 2024. The filing includes financial data for various periods, including March 31, 2024, June 30, 2023, and December 31, 2023. Key balance sheet items such as Accounts Receivable, Treasury Stock, Common Stock, Retained Earnings, Additional Paid-In Capital, Accumulated Other Comprehensive Income, and Stockholder Loans Receivable are detailed. Information regarding Employee Stock Options and Restricted Stock Units (RSUs) for the periods ending March 31, 2024, and March 31, 2023, is also present. The company's fiscal year ends on June 30.

Why It Matters

For investors and stakeholders tracking EGAIN Corp, this filing contains several important signals. This 10-Q filing provides stakeholders with the latest financial snapshot of EGAIN Corp, crucial for investment decisions and performance evaluation. The detailed breakdown of equity accounts and stock-based compensation offers insights into the company's capital structure and employee incentive programs.

Risk Assessment

Risk Level: low — EGAIN Corp shows low risk based on this filing. The filing is a standard 10-Q, which is a routine quarterly report and does not contain significant new risks or disclosures beyond typical financial reporting.

Analyst Insight

Monitor future 10-Q filings for trends in accounts receivable, treasury stock, and equity accounts to assess financial health and shareholder value.

Key Numbers

• 2024-03-31 — Reporting Period End Date (10-Q filing)
• 2023-06-30 — Comparative Balance Sheet Date (10-Q filing)
• 2023-12-31 — Comparative Balance Sheet Date (10-Q filing)
• 06-30 — Fiscal Year End (EGAIN Corp)

Key Players & Entities

• EGAIN Corp (company) — Filer of the 10-Q report
• 2024-03-31 (date) — End of the reporting period for the 10-Q
• 2023-06-30 (date) — Comparative balance sheet date
• 2023-12-31 (date) — Comparative balance sheet date
• 1934 Act (regulatory) — Securities Exchange Act under which the 10-Q is filed
• 001-35314 (regulator) — SEC file number for EGAIN Corp

FAQ

Industry Context

EGAIN Corp operates in the software services industry, specifically prepackaged software (SIC 7372).

Regulatory Implications

The filing is made under the Securities Exchange Act of 1934, requiring public companies to submit regular financial reports like the 10-Q to the SEC.

What Investors Should Do

1. Review the full 10-Q filing for detailed financial statements and management's discussion and analysis.
2. Compare the balance sheet figures for March 31, 2024, with prior periods to identify significant changes.
3. Analyze the disclosures related to stock options and RSUs for insights into executive compensation and employee incentives.

Key Dates

• 2024-03-31: Quarterly Period End — End of the reporting period for the 10-Q filing.
• 2024-05-09: Filing Date — Date the 10-Q was filed with the SEC.

Year-Over-Year Comparison

This is the initial filing data extracted; a comparison to a prior filing would require additional data.

Key Financial Figures

• $0.001 — ch registered Common Stock, par value $0.001 per share EGAN The Nasdaq Stock Mar

Filing Documents

• egan-20240331x10q.htm (10-Q) — 2162KB
• egan-20240331xex31d1.htm (EX-31.1) — 15KB
• egan-20240331xex31d2.htm (EX-31.2) — 15KB
• egan-20240331xex32d1.htm (EX-32.1) — 7KB
• egan-20240331xex32d2.htm (EX-32.2) — 7KB
• 0001558370-24-007595.txt (&nbsp;) — 6841KB
• egan-20240331.xsd (EX-101.SCH) — 34KB
• egan-20240331_cal.xml (EX-101.CAL) — 50KB
• egan-20240331_def.xml (EX-101.DEF) — 130KB
• egan-20240331_lab.xml (EX-101.LAB) — 349KB
• egan-20240331_pre.xml (EX-101.PRE) — 239KB
• egan-20240331x10q_htm.xml (XML) — 1131KB

Financial Statements (Unaudited)

Financial Statements (Unaudited) 2 Condensed Consolidated Balance Sheets as of March 31, 2024 and June 30, 2023 2 Condensed Consolidated Statements of Operations for the Three and Nine Months Ended March 31, 2024 and 2023 3 Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three and Nine Months Ended March 31, 2024 and 2023 4 Condensed Consolidated Statements of Stockholders' Equity for the Three and Nine Months Ended March 31, 2024 and 2023 5 Condensed Consolidated Statements of Cash Flows for the Nine Months Ended March 31, 2024 and 2023 9 Notes to Condensed Consolidated Financial Statements 10 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 24 Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 38 Item 4.

Controls and Procedures

Controls and Procedures 39 PART II. OTHER INFORMATION 40 Item 1.

Legal Proceedings

Legal Proceedings 40 Item 1A.

Risk Factors

Risk Factors 40 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 57 Item 5. Other Information 58 Item 6. Exhibits 59

Signatures

Signatures 60 1 Table of Contents

FINANCIAL INFORMATIO N

PART I. FINANCIAL INFORMATIO N

Financial Statements

Item 1. Financial Statements EGAIN CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except par value data) (unaudited) March 31, June 30, 2024 2023 ASSETS Current assets: Cash and cash equivalents $ 82,982 $ 73,201 Restricted cash 7 7 Accounts receivable, less provision for credit losses of $ 209 and $ 237 as of March 31, 2024 and June 30, 2023, respectively 10,950 31,569 Costs capitalized to obtain revenue contracts, net 1,247 1,317 Prepaid expenses 2,387 2,466 Other current assets 1,317 1,268 Total current assets 98,890 109,828 Property and equipment, net 483 633 Operating lease right-of-use assets 4,077 2,797 Costs capitalized to obtain revenue contracts, net of current portion 1,734 2,318 Goodwill 13,186 13,186 Other assets, net 1,954 1,355 Total assets $ 120,324 $ 130,117 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 1,534 $ 2,044 Accrued compensation 6,933 7,697 Accrued liabilities 5,615 5,387 Operating lease liabilities 1,192 832 Deferred revenue 34,342 47,762 Total current liabilities 49,616 63,722 Deferred revenue, net of current portion 3,157 2,101 Operating lease liabilities, net of current portion 2,803 1,762 Other long-term liabilities 887 836 Total liabilities 56,463 68,421 Commitments and contingencies (Note 6) Stockholders' equity: Common stock, par value $ 0.001 - authorized: 60,000 shares; issued: 32,523 and 32,268 ; outstanding: 30,382 and 31,482 shares as of March 31, 2024 and June 30, 2023, respectively 33 32 Additional paid-in capital 405,590 401,087 Treasury stock, at cost: 2,141 and 786 shares of common stock as of March 31, 2024 and June 30, 2023, respectively ( 14,292 ) ( 5,763 ) Notes receivable from stockholders ( 21 ) ( 97 ) Accumulated other comprehensive loss ( 2,282 ) ( 2,122 ) Accumulated deficit ( 325,167 ) ( 331,441 ) Tot

View Full Filing

View this 10-Q filing on SEC EDGAR